Bissonnette R - Search Results

1

Bissonnette R, Harel F, Krueger JG, Guertin MC, Chabot-Blanchet M, Gonzalez J, Maari C, Delorme I, Lynde CW, Tardif JC. Bissonnette R, et al. J Invest Dermatol. 2017 Oct;137(10):2237-2238. doi: 10.1016/j.jid.2017.05.027. Epub 2017 Jun 23. J Invest Dermatol. 2017. PMID: 28652110 Free article. No abstract available.

2

The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody.

Papp K, Bissonnette R, Krueger JG, Carey W, Gratton D, Gulliver WP, Lui H, Lynde CW, Magee A, Minier D, Ouellet JP, Patel P, Shapiro J, Shear NH, Kramer S, Walicke P, Bauer R, Dedrick RL, Kim SS, White M, Garovoy MR. Papp K, et al. Among authors: bissonnette r. J Am Acad Dermatol. 2001 Nov;45(5):665-74. doi: 10.1067/mjd.2001.117850. J Am Acad Dermatol. 2001. PMID: 11606914 Clinical Trial.

3

Repeated exposure to blue light does not improve psoriasis.

Maari C, Viau G, Bissonnette R. Maari C, et al. Among authors: bissonnette r. J Am Acad Dermatol. 2003 Jul;49(1):55-8. doi: 10.1067/mjd.2003.445. J Am Acad Dermatol. 2003. PMID: 12833008

4

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. Among authors: bissonnette r. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

5

Etanercept in the treatment of palmoplantar pustulosis.

Bissonnette R, Poulin Y, Bolduc C, Maari C, Provost N, Syrotuik J, Poulin-Costello CM, Nigen S. Bissonnette R, et al. J Drugs Dermatol. 2008 Oct;7(10):940-6. J Drugs Dermatol. 2008. PMID: 19112757 Clinical Trial.

6

Randomized study comparing the efficacy and tolerance of a lipophillic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris.

Bissonnette R, Bolduc C, Seité S, Nigen S, Provost N, Maari C, Rougier A. Bissonnette R, et al. J Cosmet Dermatol. 2009 Mar;8(1):19-23. doi: 10.1111/j.1473-2165.2009.00418.x. J Cosmet Dermatol. 2009. PMID: 19250161 Clinical Trial.

7

The AWARE study: methodology and baseline characteristics.

Bissonnette R, Searles G, Landells I, Shear NH, Papp K, Lui H, Gulliver WP, Lynde C. Bissonnette R, et al. J Cutan Med Surg. 2009 Dec;13 Suppl 3:S113-21. doi: 10.2310/7750.2009.00029. J Cutan Med Surg. 2009. PMID: 20053323 Clinical Trial.

8

A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis.

Bissonnette R, Papp K, Maari C, Yao Y, Robbie G, White WI, Le C, White B. Bissonnette R, et al. J Am Acad Dermatol. 2010 Mar;62(3):427-36. doi: 10.1016/j.jaad.2009.05.042. J Am Acad Dermatol. 2010. PMID: 20159310 Clinical Trial.

9

A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis.

Bissonnette R, Maari C, Provost N, Bolduc C, Nigen S, Rougier A, Seite S. Bissonnette R, et al. J Cosmet Dermatol. 2010 Mar;9(1):16-21. doi: 10.1111/j.1473-2165.2010.00476.x. J Cosmet Dermatol. 2010. PMID: 20367668 Clinical Trial.

10

Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial.

Bissonnette R, Chen G, Bolduc C, Maari C, Lyle M, Tang L, Webster J, Zhou Y. Bissonnette R, et al. Arch Dermatol. 2010 Apr;146(4):446-9. doi: 10.1001/archdermatol.2010.34. Arch Dermatol. 2010. PMID: 20404242 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page